Dhiti Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 07-07-2024
- Paid Up Capital ₹ 0.10 M
as on 07-07-2024
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.26 Cr
as on 07-07-2024
- Revenue -6.31%
(FY 2023)
- Profit -58.14%
(FY 2023)
- Ebitda -40.11%
(FY 2023)
- Net Worth 8.47%
(FY 2023)
- Total Assets 70.68%
(FY 2023)
About Dhiti Life Sciences
The Corporate was formerly known as Veexl Engineering Solutions Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.26 Cr.
Abhinav Shrestha, Naresh Singh, and Savita Sekhri serve as directors at the Company.
- CIN/LLPIN
U24233DL2010PTC202366
- Company No.
202366
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 May 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Dhiti Life Sciences Private Limited offer?
Dhiti Life Sciences Private Limited offers a wide range of products and services, including Copywriting & Content Development, Content Writing Service, Research and Development (R&D) Work, Product Development Research.
Who are the key members and board of directors at Dhiti Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Savita Sekhri  | Additional Director | 06-Mar-2024 | Current |
| Abhinav Shrestha | Director | 20-Feb-2020 | Current |
| Naresh Singh | Director | 06-May-2010 | Current |
Financial Performance of Dhiti Life Sciences.
Dhiti Life Sciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.31% decrease. The company also saw a substantial fall in profitability, with a 58.14% decrease in profit. The company's net worth moved up by a moderate rise of 8.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dhiti Life Sciences?
In 2023, Dhiti Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
O2 Pathlabs Private LimitedActive 8 years 6 monthsAbhinav Shrestha and Naresh Singh are mutual person
Oscar Medicare Private LimitedActive 17 years 8 monthsNaresh Singh and Savita Sekhri are mutual person
Dhiti Biotech (India) Private LimitedActive 22 years 10 monthsNaresh Singh and Savita Sekhri are mutual person
- Dhiti Biologicals Private LimitedActive 3 years 2 months
Naresh Singh and Savita Sekhri are mutual person
- Dhiti Biomedical Devices Private LimitedActive 3 years 2 months
Naresh Singh and Savita Sekhri are mutual person
Charges (Loans)
₹22.64 M
₹0
Charges Breakdown by Lending Institutions
- Corporation Bank : 1.30 Cr
- Others : 0.96 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Mar 2017 | Others | ₹4.50 M | Open |
| 22 Dec 2016 | Others | ₹2.00 M | Open |
| 10 Aug 2016 | Others | ₹2.45 M | Open |
| 23 Jun 2016 | Others | ₹0.69 M | Open |
| 27 Jul 2013 | Corporation Bank | ₹3.00 M | Open |
How Many Employees Work at Dhiti Life Sciences?
Unlock and access historical data on people associated with Dhiti Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dhiti Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dhiti Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
